User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Is serum galectin-3 a potential predictor of the response to active specific immunotherapy in melanoma patients?

  1. May A, Cancer Lett, 81 (1994)
  2. Iurisci I, Clin Cancer Res, 6 (2000)
  3. Vereecken P, Arch Dermatol Res, 296 (2005)
  4. Vereecken P, Clin Exp Dermatol, 31 (2006)
  5. Califice S, Int J Oncol, 25 (2004)
  6. Rubinstein N, Cancer Cell, 5 (2004)
  7. Almkvist J, Glycoconj J, 19 (2004)
  8. Fukumori T, Cancer Res, 64 (2004)
  9. Balch CM, J Clin Oncol, 19 (2001)
Bibliographic reference Vereecken, Pierre ; Heenen, Michel ; Babar, Sajida ; van Baren, Nicolas. Is serum galectin-3 a potential predictor of the response to active specific immunotherapy in melanoma patients?. In: Journal of the European Academy of Dermatology and Venereology, Vol. 21, no. 2, p. 278-280 (2007)
Permanent URL http://hdl.handle.net/2078.1/124170